Vertebral Compression Fracture Devices Market

In this report, the Vertebral Compression Fracture Devices Market has been segmented by Surgery, Material, Procedure Type, End Use and Geography.

Vertebral Compression Fracture Devices Market, Segmentation by Surgery

The Vertebral Compression Fracture Devices Market is segmented by Minimally Invasive Spine Surgery and Open Spine Surgery.

Minimally Invasive Spine Surgery

The minimally invasive spine surgery segment holds about 65 % of the vertebral compression fracture devices market as of 2024. It offers smaller incisions, less blood loss, faster recovery, lower infection risk, and reduced dependence on pain medication. Many of these procedures are performed on an outpatient basis, enhancing cost efficiency and patient convenience.

Open Spine Surgery

The open spine surgery segment represents roughly 35 % of the market in 2024. This approach remains vital for cases involving complex or multi‑level fractures that are not suitable for minimally invasive techniques. It requires larger incisions, longer hospital stays, and more intensive post‑operative care—but is often the preferred option when direct anatomical access and repair are critical.

Vertebral Compression Fracture Devices Market, Segmentation by Material

The Vertebral Compression Fracture Devices Market is segmented by PMMA Bone Cement, Bio-Active/Bioresorbable Cement, and More.

PMMA Bone Cement

The PMMA bone cement category led the vertebral compression fracture devices market in 2024, holding an estimated 56.7 % share. Its notable strength, immediate stabilization, and decades‑long clinical familiarity make it the primary choice for vertebroplasty and kyphoplasty. Even with the exothermic setting process, PMMA remains cost‑competitive and trusted due to reliable delivery systems and surgeon experience.

Bio‑Active/Bioresorbable Cement

Forecasted to grow at around 12.7 % annually, bio‑active and bioresorbable cements are becoming more popular for their enhanced osteoconductivity and ability to support bone remodeling. Variants like calcium‑phosphate or ceramic hybrids gradually resorb while assisting tissue integration, reducing long‑term foreign‑body presence and improving biological compatibility.

More

The category of other material types includes antibiotic-loaded cements, advanced composite blends, and emerging biomaterials. While no individual solution dominates, together they represent a meaningful slice of the market—particularly in cases demanding high biocompatibility or infection control. This diversity underscores ongoing innovation and targeted application in specialized treatment scenarios.

The Vertebral Compression Fracture Devices Market, Segmentation by Procedure Type

TheVertebral Compression Fracture Devices Market is segmented by procedure type into Vertebroplasty, Balloon Kyphoplasty, and Others.

The vertebroplasty procedure makes up about 40 % of the global devices market for vertebral compression fractures. It delivers efficient pain relief and spinal stabilization via direct cement injection. While it offers a cost-effective outpatient solution, its limited ability for structural restoration compared to balloon techniques often restricts its use in complex fracture scenarios.

Comprising roughly 60 % of the market in 2023, balloon kyphoplasty generated over USD 1,038 million in revenue. Favored for its ability to restore vertebral height and reduce cement leakage, kyphoplasty consistently outperforms vertebroplasty in pain relief and functional recovery, contributing to its widespread clinical adoption.

The category of other procedures and emerging technologies covers minimally utilized but growing alternatives within the vertebral compression fracture devices space. These innovations leverage advanced biomaterials, refined delivery systems, and novel augmentation approaches to treat niche cases, supporting innovation and broadening treatment options.

Vertebral Compression Fracture Devices Market, Segmentation by End Use

The Vertebral Compression Fracture Devices Market is segmented by end use into hospitals, ambulatory surgical centers (ASCs), trauma centers, and others.

Hospitals

The hospital segment commanded approximately 53 % of the vertebral compression fracture devices market in 2024. These institutions offer comprehensive care with advanced diagnostics, surgical suites, and specialist teams, positioning them as the primary choice for complex spinal procedures.

The ambulatory surgical centers segment is growing rapidly at around an 11 % CAGR through 2030. ASCs provide cost‑effective outpatient care, with quick turnover and minimal hospital stay—ideal for minimally invasive treatments such as vertebroplasty and kyphoplasty.

In acute cases, trauma centers are essential for stabilizing severe, multi-level vertebral fractures. Though they account for a smaller percentage of procedures, their role in emergent fracture care remains critical.

The category of other end users includes specialty spine clinics, rehabilitation centers, and outpatient orthopaedics. These facilities serve a meaningful segment of the market by focusing on elective augmentation, osteoporosis management, and targeted spine care outside hospital or ASC environments.